Find a Laboratory Jed Nuchtern, MD

Jed G. Nuchtern, MD

Chief of Global Surgery

Jed Nuchtern

Professor of Surgery and Pediatrics, Baylor College of Medicine


School Education Degree Year
Baylor College of Medicine Residency Pediatric Surgery 1995
University of Washington Residency General Surgery 1992
NIH/NIAID Fellowship IRTA Fellow 1990
University of Washington Residency General Surgery 1988
University of Washington Internship General Surgery 1986
Harvard Medical School Medical School Doctor of Medicine 1985



Dr. Jed Nuchtern is a pediatric surgeon specializing in pediatric surgical oncology. In addition to performing general neonatal and pediatric surgery, he is a member of the Surgical Oncology Team at Texas Children's Hospital and is actively involved with taking care of patients with neuroblastoma, liver cancer, renal tumors and sarcomas.

In his general surgery practice, Dr. Nuchtern also has specialized expertise in pectus excavatum and carinatum repair.

Dr. Nuchtern is certified by the American Board of Surgery in General Surgery, Pediatric Surgery and Surgical Critical Care.



Organization Name Role
American Academy of Pediatrics (AAP), Surgical Section Fellow
American College of Surgeons (ACS) Fellow; Member, Commission on Cancer
American Pediatric Surgical Association Member
Association for Academic Surgery Member
Commission on Cancer, American College of Surgeons Member
International Society for Pediatric Surgical Oncology Member
Pediatric Oncology Group/Children's Oncology Group (COG) Member
Society of Critical Care Medicine Member
Society of University Surgeons Member
Southwestern Surgical Congress Member


Research Statement

Dr. Nuchtern's research program includes translational and clinical research on developing new treatments for pediatric solid tumors, particularly neuroblastoma. The primary focus in the laboratory is identifying new targets for neuroblastoma therapy; current research is directed toward identifying the pathways through which these molecules affect tumor progression. In addition to these translational studies, Dr. Nuchtern is involved in clinical research on neuroblastoma in infants. Through the Children's Oncology Group, he designed and implemented a prospective international study investigating the safety and efficacy of expectant observation as the primary treatment modality for infants with low risk adrenal tumors. He is a member of the Carl C. Anderson, Sr. and Marie Jo Anderson Charitable Foundation Laboratory for Neuroblastoma Research as well as the Texas Children's Liver Tumor Center.

Selected Publications

View All Publications

* Texas Children's Hospital physicians' licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician's office and were not verified by Texas Children's Hospital.